Beyond Next Ventures

Beyond Next Ventures Co., Ltd. is a Tokyo-based venture capital firm founded in 2014. The firm focuses on incubating and investing in seed, start-up, and early-growth companies across various sectors, with a strong emphasis on medical and healthcare industries. Additionally, it explores opportunities in electronics, information technology, agriculture, food, biotechnology, drug discovery, digital technology, space, and climate technology. Beyond Next Ventures primarily targets companies located in Japan and India, aiming to support innovative solutions and advancements in these fields.

Katsuya Hashizume

Executive Officer & Partner

Tsuyoshi Ito

Chief Executive Officer & Managing Partner

Masahiro Kanamaru

Investor

Kengo Ueha

Managing Director

Past deals in Tokyo

LIFESCAPES

Seed Round in 2022
LIFESCAPES is a researcher and manufacturer of brain-computer interface equipment. LIFESCAPES aims to use BMI technology to help stroke patients solve problems and improve their quality of life. LIFESCAPES uses BMI to bring out the plasticity of the brain and help people who are in trouble to be free of their limitations and to live their lives normally.

Integriculture

Series A in 2022
Integriculture makes cellular agriculture products to improve sustainability, food security, and reduce public health problems. The company offers a developed patented general-purpose large-scale cell culture system that can culture wide range of cells without external addition of expensive growth factors and provide consumers with affordable clean meat. Founded in 2015, Integriculture is headquartered in Tokyo, Japan.

Secai Marche

Seed Round in 2021
Secai Marche Inc. operates a platform that facilitates direct connections between farmers, chefs, and consumers, aiming to enhance the sustainability and economic viability of small-scale farms globally. Founded in 2018 and headquartered in Tokyo, Japan, with an additional office in Kuala Lumpur, Malaysia, the company offers services that encompass sourcing, order processing, payment, and delivery. Through its offerings, such as Secai Marche and the sanchoku platform, it enables restaurants to purchase high-quality products directly from farmers. This approach not only supports local agriculture but also promotes access to quality food for businesses and consumers alike.

Libero Thera

Venture Round in 2021
LiberoThera Co., Ltd. engages in the discovery of drugs targeting on membrane proteins for the medical care industry. It also offers drug discovery services. The company was founded in 2018 and is based in Tokyo, Japan.

Medita

Venture Round in 2021
Medita is a technology company that provides medical equipment, health consulting, and welfare services.

I'mbesideyou

Seed Round in 2021
Multimodal AI analytics for online communicaiotn

Gojo & Company

Series D in 2020
Gojo & Company Inc. is a holding company based in Tokyo, Japan, that operates through its subsidiaries, including Microfinance Delta International and Sejaya Micro Credit, to provide microfinance services. Founded in 2014, the company aims to enhance financial inclusion by focusing on developing countries. Gojo supports the formalization and growth of micro, small, and medium-sized enterprises, with the long-term objective of delivering high-quality, affordable financial services to over 100 million unserved and underserved individuals across more than 50 countries by 2030. As of now, Gojo has established a presence in Cambodia, Myanmar, Sri Lanka, and India, employing over 3,400 individuals and serving more than 570,000 women, many of whom are mothers.

Integriculture

Series A in 2020
Integriculture makes cellular agriculture products to improve sustainability, food security, and reduce public health problems. The company offers a developed patented general-purpose large-scale cell culture system that can culture wide range of cells without external addition of expensive growth factors and provide consumers with affordable clean meat. Founded in 2015, Integriculture is headquartered in Tokyo, Japan.

PRECISION Japan

Venture Round in 2020
Precision is a Medical care and the social situation surrounding it are changing dramatically, and the amount of information and work required at medical sites is increasing at an accelerating rate.

Secai Marche

Seed Round in 2019
Secai Marche Inc. operates a platform that facilitates direct connections between farmers, chefs, and consumers, aiming to enhance the sustainability and economic viability of small-scale farms globally. Founded in 2018 and headquartered in Tokyo, Japan, with an additional office in Kuala Lumpur, Malaysia, the company offers services that encompass sourcing, order processing, payment, and delivery. Through its offerings, such as Secai Marche and the sanchoku platform, it enables restaurants to purchase high-quality products directly from farmers. This approach not only supports local agriculture but also promotes access to quality food for businesses and consumers alike.

POL

Series A in 2019
POL is creating a platform that maximizes the possibilities of researchers. It is a laboratory that is a place where innovative science and technology are created that greatly advances society. Its first project "LabBase" would like to create a society that can solve problems in job hunting for science-based human resources, issues of companies wanting to adopt them, issues faced by laboratories, and so that science-based human resources can be used more effectively.

iCARE

Venture Round in 2019
iCARE Co., Ltd. is a Tokyo-based company established in 2011 that specializes in health management systems. It operates a cloud-based platform designed to manage and store health information for employees. iCARE is recognized as the leading health and labor cloud service in Japan, catering to the needs of both small and medium-sized enterprises experiencing workforce challenges, as well as large corporations seeking to expand globally. The company's focus on health consulting and the development of effective health management solutions positions it as a key player in the evolving landscape of employee health services.

FullDepth

Venture Round in 2019
FullDepth Co., Ltd. designs and manufactures underwater drone. Its products include FullDepth DiveUnit 300 and TripodFinder, an underwater remote operated vehicle used to explore the known and unknown submarine world. FullDepth Co., Ltd. was formerly known as Ambient Intelligence Technologies Lab., Co. Ltd and changed its name to FullDepth Co., Ltd. in March, 2018. The company was founded in 2014 and is based in Tsukuba, Japan.

Aillis

Venture Round in 2019
Aillis specializes in the development of testing methods for Influenza using artificial intelligence technology. The company mainly focuses on new methods of diagnosing influenza. The company was founded in 2017.

Academist

Series A in 2019
Academist is a crowdfunding platform that specializes in acquiring research funds. Through Academist, researchers can raise research expenses from a large number of unspecified supporters through the Internet. All supporters can directly help interested researchers and research themes in the form of research support. The company contributes to the future academic situation by managing services. Academist was founded in April 2013 and is headquartered in Tokyo, Japan.

miup

Venture Round in 2018
Miup, Inc. is a healthcare company based in Tokyo, Japan, founded in 2015. The organization focuses on providing medical care services both in Asia and internationally. Miup aims to enhance healthcare delivery by collecting and analyzing vital data, particularly in emerging countries. The company's strategy emphasizes prevention and medical care, leveraging machine learning to improve diagnostic assistance and risk prediction accuracy. By creating a healthcare ecosystem that integrates health management, diagnosis support, and prevention, Miup seeks to establish itself as an essential entity in the global healthcare landscape, ultimately delivering direct medical care to individuals worldwide.

Xenoma

Venture Round in 2018
Xenoma Inc. is a spin-off company from Someya Group Organic Transistor Lab in the University of T[okyo and JST/ERATO Someya Bio-Harmonized Electronics Project. Professor Takao Someya have been dealing with Organic Electronics since 2003. His ultrathin and ultraflexible device is harmoniously interface with human bodies by taking advantage of the inherent softness of organic materials. Xenoma is aiming at realizing e-skin, which is a next-generation textile-based wearable electronics as an ideal interface between human and device.

Sustainable Medicine

Venture Round in 2018
Sustainable Medicine, Inc. engages in development of medical software application for treating insomnia. The company was founded in 2015 and is based in Tokyo, Japan.

Integriculture

Seed Round in 2018
Integriculture makes cellular agriculture products to improve sustainability, food security, and reduce public health problems. The company offers a developed patented general-purpose large-scale cell culture system that can culture wide range of cells without external addition of expensive growth factors and provide consumers with affordable clean meat. Founded in 2015, Integriculture is headquartered in Tokyo, Japan.

Lily MedTech

Series A in 2018
Lily MedTech Inc. develops and manufactures medical device including ultrasound diagnostic imaging equipment for breast cancer. The company was founded in 2016 and is headquartered in Tokyo, Japan.

iCARE

Venture Round in 2018
iCARE Co., Ltd. is a Tokyo-based company established in 2011 that specializes in health management systems. It operates a cloud-based platform designed to manage and store health information for employees. iCARE is recognized as the leading health and labor cloud service in Japan, catering to the needs of both small and medium-sized enterprises experiencing workforce challenges, as well as large corporations seeking to expand globally. The company's focus on health consulting and the development of effective health management solutions positions it as a key player in the evolving landscape of employee health services.

Riverfield

Series B in 2017
Riverfield, Inc. is a Tokyo-based company founded in 2014 that specializes in developing surgical support robotic systems for the healthcare industry. The company focuses on creating innovative robotic technologies designed to enhance surgical procedures and improve patient outcomes. Riverfield aims to address the growing demand for advanced medical solutions by leveraging robotics to assist healthcare professionals in their work.

Xenoma

Series A in 2017
Xenoma Inc. is a spin-off company from Someya Group Organic Transistor Lab in the University of T[okyo and JST/ERATO Someya Bio-Harmonized Electronics Project. Professor Takao Someya have been dealing with Organic Electronics since 2003. His ultrathin and ultraflexible device is harmoniously interface with human bodies by taking advantage of the inherent softness of organic materials. Xenoma is aiming at realizing e-skin, which is a next-generation textile-based wearable electronics as an ideal interface between human and device.

FullDepth

Venture Round in 2017
FullDepth Co., Ltd. designs and manufactures underwater drone. Its products include FullDepth DiveUnit 300 and TripodFinder, an underwater remote operated vehicle used to explore the known and unknown submarine world. FullDepth Co., Ltd. was formerly known as Ambient Intelligence Technologies Lab., Co. Ltd and changed its name to FullDepth Co., Ltd. in March, 2018. The company was founded in 2014 and is based in Tsukuba, Japan.

POL

Seed Round in 2017
POL is creating a platform that maximizes the possibilities of researchers. It is a laboratory that is a place where innovative science and technology are created that greatly advances society. Its first project "LabBase" would like to create a society that can solve problems in job hunting for science-based human resources, issues of companies wanting to adopt them, issues faced by laboratories, and so that science-based human resources can be used more effectively.

Myoridge

Seed Round in 2017
Myoridge Co. Ltd. develops suspension culture system for scalably differentiating pluripotent cells into desired lineages including cardiomyocytes using a novel small-molecule compound and without requiring proteins. The company’s products include iPS cell derived cardiomyocytes, cardiomyocyte fiber, and software for myocardial motion/ fluorescence analysis. The company was founded in 2016 and is based in Kyoto, Japan.

Sustainable Medicine

Seed Round in 2017
Sustainable Medicine, Inc. engages in development of medical software application for treating insomnia. The company was founded in 2015 and is based in Tokyo, Japan.

CureApp

Series A in 2017
CureApp is a digital health startup.The firm is one of the leading players in the medical app vertical under the theme of “app exhibits therapeutic effects against diseases” and launched a nicotine addiction treatment app in February 2015, which was jointly developed with Division of Pulmonary Medicine, Keio University’s School of Medicine. It is currently conducting clinical trials in many locations.

OryLab

Venture Round in 2016
OryLab is a manufacturing and sales of communication technology company.

Xenoma

Seed Round in 2016
Xenoma Inc. is a spin-off company from Someya Group Organic Transistor Lab in the University of T[okyo and JST/ERATO Someya Bio-Harmonized Electronics Project. Professor Takao Someya have been dealing with Organic Electronics since 2003. His ultrathin and ultraflexible device is harmoniously interface with human bodies by taking advantage of the inherent softness of organic materials. Xenoma is aiming at realizing e-skin, which is a next-generation textile-based wearable electronics as an ideal interface between human and device.

Riverfield

Venture Round in 2016
Riverfield, Inc. is a Tokyo-based company founded in 2014 that specializes in developing surgical support robotic systems for the healthcare industry. The company focuses on creating innovative robotic technologies designed to enhance surgical procedures and improve patient outcomes. Riverfield aims to address the growing demand for advanced medical solutions by leveraging robotics to assist healthcare professionals in their work.

Elephantech

Seed Round in 2016
Elephantech Inc., founded in January 2014 and based in Tokyo, Japan, focuses on innovating the manufacturing of electronic circuits. The company seeks to revolutionize this field by employing inkjet printing technology, which allows for the precise application of metal only where needed, in contrast to traditional photolithography methods that waste materials and increase costs. This novel approach not only reduces the quantity of materials used but also minimizes the number of manufacturing processes, resulting in a significant cost reduction of up to 80% for prototype production. Elephantech's technology is particularly advantageous for on-demand manufacturing, making it an appealing option for small-batch production without the need for substantial initial investment. With a commitment to enhancing global manufacturing capabilities, Elephantech aims to lead the industry with its advanced techniques for producing printed wiring boards.

CureApp

Seed Round in 2015
CureApp is a digital health startup.The firm is one of the leading players in the medical app vertical under the theme of “app exhibits therapeutic effects against diseases” and launched a nicotine addiction treatment app in February 2015, which was jointly developed with Division of Pulmonary Medicine, Keio University’s School of Medicine. It is currently conducting clinical trials in many locations.